Early Detection of Severe Acute Respiratory Syndrome Coronavirus 2 Variants Using Traveler-based Genomic Surveillance at 4 US Airports, September 2021-January 2022.

Wegrzyn, Renee D; Appiah, Grace D; Morfino, Robert; Milford, Scott R; Walker, Allison Taylor; Ernst, Ezra T; Darrow, William W; Li, Siyao Lisa; Robison, Keith; MacCannell, Duncan; Dai, Dongjuan; Girinathan, Brintha P; Hicks, Allison L; Cosca, Bryan; Woronoff, Gabrielle; Plocik, Alex M; Simen, Birgitte B; Moriarty, Leah; Guagliardo, Sarah Anne J; Cetron, Martin S; Friedman, Cindy R

Wegrzyn, Renee D; Appiah, Grace D; Morfino, Robert; Milford, Scott R; Walker, Allison Taylor; Ernst, Ezra T; Darrow, William W; Li, Siyao Lisa; Robison, Keith; MacCannell, Duncan; Dai, Dongjuan; Girinathan, Brintha P; Hicks, Allison L; Cosca, Bryan; Woronoff, Gabrielle; Plocik, Alex M; Simen, Birgitte B; Moriarty, Leah; Guagliardo, Sarah Anne J; Cetron, Martin S; Friedman, Cindy R.

Afiliação

Wegrzyn RD; Ginkgo Bioworks, Inc, Boston, Massachusetts, USA.
Appiah GD; Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Morfino R; Ginkgo Bioworks, Inc, Boston, Massachusetts, USA.
Milford SR; XpresCheck™, XpresSpa™, New York, NY, USA.
Walker AT; Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Ernst ET; XpresCheck™, XpresSpa™, New York, NY, USA.
Darrow WW; XpresCheck™, XpresSpa™, New York, NY, USA.
Li SL; Ginkgo Bioworks, Inc, Boston, Massachusetts, USA.
Robison K; Ginkgo Bioworks, Inc, Boston, Massachusetts, USA.
MacCannell D; Office of Advanced Molecular Detection, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Dai D; Ginkgo Bioworks, Inc, Boston, Massachusetts, USA.
Girinathan BP; Ginkgo Bioworks, Inc, Boston, Massachusetts, USA.
Hicks AL; Ginkgo Bioworks, Inc, Boston, Massachusetts, USA.
Cosca B; Ginkgo Bioworks, Inc, Boston, Massachusetts, USA.
Woronoff G; Ginkgo Bioworks, Inc, Boston, Massachusetts, USA.
Plocik AM; Ginkgo Bioworks, Inc, Boston, Massachusetts, USA.
Simen BB; Ginkgo Bioworks, Inc, Boston, Massachusetts, USA.
Moriarty L; Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Guagliardo SAJ; Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Cetron MS; Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Friedman CR; Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Clin Infect Dis ; 76(3): e540-e543, 2023 02 08.

Article em En | MEDLINE | ID: mdl-35686436

ABSTRACT

ABSTRACT

We enrolled arriving international air travelers in a severe acute respiratory syndrome coronavirus 2 genomic surveillance program. We used molecular testing of pooled nasal swabs and sequenced positive samples for sublineage. Traveler-based surveillance provided early-warning variant detection, reporting the first US Omicron BA.2 and BA.3 in North America.

Assuntos

COVID-19; SARS-CoV-2; Humanos; SARS-CoV-2/genética; Aeroportos; COVID-19/diagnóstico; Genômica

Palavras-chave

SARS-CoV-2; genomic surveillance; international travelers

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google